The ability of oxidised PTEN to regain its tumour suppressive activity depends on the capacity of thioredoxin to reduce the inactive form, and a total loss of PTEN function can occur if the redox status of the cell is abnormal (Lee et al, 2002; Kwon et al, 2004). The gene discussed is TXN; the disease is neoplasm.